Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is now covered by analysts at BMO Capital Markets. They set a "buy" rating and a $65.00 price target on the stock.

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com